Matches in Wikidata for { <http://www.wikidata.org/entity/Q73504130> ?p ?o ?g. }
- Q73504130 description "article scientifique publié en 1997" @default.
- Q73504130 description "artikull shkencor i botuar më 01 janar 1997" @default.
- Q73504130 description "artículu científicu espublizáu en xineru de 1997" @default.
- Q73504130 description "im Januar 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73504130 description "scientific article published on 01 January 1997" @default.
- Q73504130 description "wetenschappelijk artikel" @default.
- Q73504130 description "наукова стаття, опублікована в січні 1997" @default.
- Q73504130 name "Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer" @default.
- Q73504130 name "Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer" @default.
- Q73504130 name "Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer" @default.
- Q73504130 type Item @default.
- Q73504130 label "Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer" @default.
- Q73504130 label "Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer" @default.
- Q73504130 label "Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer" @default.
- Q73504130 prefLabel "Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer" @default.
- Q73504130 prefLabel "Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer" @default.
- Q73504130 prefLabel "Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer" @default.
- Q73504130 P1433 Q73504130-B017D6C0-A2EA-42A8-A8A5-0782B578147E @default.
- Q73504130 P1476 Q73504130-193D6BAF-2C50-409F-B7F1-ED304E151284 @default.
- Q73504130 P2093 Q73504130-00ACC39D-D156-4F0E-9C83-A408A05E4429 @default.
- Q73504130 P2093 Q73504130-267666C9-7D89-4866-9955-3EB7153F98E4 @default.
- Q73504130 P2093 Q73504130-391CE064-CE82-40ED-8F3E-333494C2F91A @default.
- Q73504130 P2093 Q73504130-458E619E-DDEB-4D8C-9249-430C6E378DB5 @default.
- Q73504130 P2093 Q73504130-75C6B3A3-F548-407B-BC3E-7DED55E6A6A8 @default.
- Q73504130 P2093 Q73504130-BFC4EB09-D4A8-4B16-AC6F-673D59E0D6CF @default.
- Q73504130 P2860 Q73504130-054B20A0-5678-4607-9349-567CE3B8D331 @default.
- Q73504130 P2860 Q73504130-076A7DFF-0F58-4DCA-A173-2A08A62A4C47 @default.
- Q73504130 P2860 Q73504130-12AECD97-2BA6-4668-B73D-584B70529A48 @default.
- Q73504130 P2860 Q73504130-132AB791-D544-45E2-8978-B7301DC72700 @default.
- Q73504130 P2860 Q73504130-1EE2F7B9-1182-473F-99E6-26388ED753BA @default.
- Q73504130 P2860 Q73504130-20E4E705-35B2-46D7-82F2-528FD39F49D0 @default.
- Q73504130 P2860 Q73504130-237EA382-0FAF-4EF6-B1AB-CF8EB42DBCE9 @default.
- Q73504130 P2860 Q73504130-3E487DFE-09E5-481F-BFCA-178BF5050670 @default.
- Q73504130 P2860 Q73504130-414759B5-1BCF-47DB-AF77-5C9CD51E3E9F @default.
- Q73504130 P2860 Q73504130-4DF3C0FC-D0C6-4E15-ADC2-3B0A202A21BF @default.
- Q73504130 P2860 Q73504130-778CCCBF-E81A-4142-BBD6-EC5BE466BA7E @default.
- Q73504130 P2860 Q73504130-77C2851E-DB40-40A0-A8EE-FE7051B7E7F4 @default.
- Q73504130 P2860 Q73504130-7AC76469-4027-480C-A3AA-19C461ADF03B @default.
- Q73504130 P2860 Q73504130-7D6688C4-4D17-4039-A43A-1FEEEBE02619 @default.
- Q73504130 P2860 Q73504130-7F472F83-483E-415F-A29E-810A724ABEE4 @default.
- Q73504130 P2860 Q73504130-80830BD2-5A0F-4959-B0AF-C636CE40C4B1 @default.
- Q73504130 P2860 Q73504130-8DBC6496-837C-42F8-9C8E-5E418299CFAD @default.
- Q73504130 P2860 Q73504130-9C119F43-2874-4EA9-B9F9-A358938745D9 @default.
- Q73504130 P2860 Q73504130-9F0C5CC7-0D0D-424F-B368-9F16E2BE8783 @default.
- Q73504130 P2860 Q73504130-A762E444-72EA-4748-8CC9-89FFAE0FD892 @default.
- Q73504130 P2860 Q73504130-ACD10EC1-3B3D-411F-ACA5-C0A832060422 @default.
- Q73504130 P2860 Q73504130-D1C0583E-D8F0-4631-B801-01C7ADFB2303 @default.
- Q73504130 P2860 Q73504130-DE8E59E0-32C4-43BE-9C66-57AFE5A50F27 @default.
- Q73504130 P2860 Q73504130-EC1B7E1A-B0AE-42FD-873D-21130EE25D54 @default.
- Q73504130 P2860 Q73504130-F6AF9472-6F8A-49B7-8671-22362EBE3579 @default.
- Q73504130 P2860 Q73504130-FCEE02D0-5F2A-4810-B73D-FB35DD75E1C3 @default.
- Q73504130 P2888 Q73504130-32B3D5B8-AB02-4125-AA2B-7ED25C13F366 @default.
- Q73504130 P304 Q73504130-AA3E6F8C-9411-44E3-B3A1-5B1720DDBB97 @default.
- Q73504130 P31 Q73504130-C1007390-F339-42A8-AB43-F6A29D8079EB @default.
- Q73504130 P356 Q73504130-59246642-C0FB-4686-B434-C8BDA78A2A8B @default.
- Q73504130 P433 Q73504130-04C77D2B-A86B-425F-B06F-D61AA6B5528F @default.
- Q73504130 P478 Q73504130-1EFBD326-51D3-495E-BD91-ED906EF09385 @default.
- Q73504130 P577 Q73504130-A95685D1-E8EA-46AF-AB61-9369A8CA5C33 @default.
- Q73504130 P6179 Q73504130-232ADFB8-F4F5-4340-AC1D-4A3C572AF9FA @default.
- Q73504130 P698 Q73504130-258A782F-CBB4-447F-B9B5-F1D334E17CAC @default.
- Q73504130 P921 Q73504130-93125727-04DC-4644-A6E6-F34956663405 @default.
- Q73504130 P921 Q73504130-E437B765-5C7A-46C7-A472-C2504B5F9110 @default.
- Q73504130 P356 A:1005812923473 @default.
- Q73504130 P698 9220293 @default.
- Q73504130 P1433 Q2312231 @default.
- Q73504130 P1476 "Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer" @default.
- Q73504130 P2093 "A Hageboutros" @default.
- Q73504130 P2093 "F Greene" @default.
- Q73504130 P2093 "F P LaCreta" @default.
- Q73504130 P2093 "G R Hudes" @default.
- Q73504130 P2093 "J Brennan" @default.
- Q73504130 P2093 "P J O'Dwyer" @default.
- Q73504130 P2860 Q29620070 @default.
- Q73504130 P2860 Q36713619 @default.
- Q73504130 P2860 Q38602796 @default.
- Q73504130 P2860 Q39586961 @default.
- Q73504130 P2860 Q39653920 @default.
- Q73504130 P2860 Q39726425 @default.
- Q73504130 P2860 Q39819970 @default.
- Q73504130 P2860 Q40281251 @default.
- Q73504130 P2860 Q41632046 @default.
- Q73504130 P2860 Q42134170 @default.
- Q73504130 P2860 Q44664927 @default.
- Q73504130 P2860 Q45159770 @default.
- Q73504130 P2860 Q45938940 @default.
- Q73504130 P2860 Q46065562 @default.
- Q73504130 P2860 Q68043719 @default.
- Q73504130 P2860 Q68054401 @default.
- Q73504130 P2860 Q68056139 @default.
- Q73504130 P2860 Q68207046 @default.
- Q73504130 P2860 Q70806158 @default.
- Q73504130 P2860 Q71050149 @default.
- Q73504130 P2860 Q71681315 @default.
- Q73504130 P2860 Q72089710 @default.
- Q73504130 P2860 Q72368981 @default.
- Q73504130 P2860 Q72410427 @default.
- Q73504130 P2860 Q72660726 @default.
- Q73504130 P2860 Q93672791 @default.
- Q73504130 P2888 a:1005812923473 @default.
- Q73504130 P304 "139-145" @default.